Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Langenbeck'S Archives of Surgery
|
December 23, 2021
Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture
U Krafft, O Mahmoud, J Hess, et al.
Der Urologe. Ausg. A
|
May 12, 2016
[Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy]
C Kesch, J P Radtke, F Distler, et al.
Pathology Oncology Research : POR
|
June 29, 2019
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients
U Krafft, S Tschirdewahn, J Hess, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 2, 2020
First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using <sup>68</sup>Ga-PSMA-11
Christopher Darr, U Krafft, W P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 27, 2012
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A Afshar-Oromieh, A Malcher, M Eder, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 6, 2013
Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A Afshar-Oromieh, A Malcher, M Eder, et al.
Molecular Imaging and Biology
|
September 5, 2019
Whole-Body Integrated [<sup>68</sup>Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference
Nika Guberina, P Hetkamp, H Ruebben, et al.
Prostate Cancer and Prostatic Diseases
|
May 18, 2016
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance
J P Radtke, T H Kuru, D Bonekamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2019
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
E J Small, F Saad, S Chowdhury, et al.
Prostate Cancer and Prostatic Diseases
|
June 17, 2015
Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance
J P Radtke, S Boxler, T H Kuru, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Langenbeck'S Archives of Surgery
|
December 23, 2021
Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture
U Krafft, O Mahmoud, J Hess, et al.
Der Urologe. Ausg. A
|
May 12, 2016
[Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy]
C Kesch, J P Radtke, F Distler, et al.
Pathology Oncology Research : POR
|
June 29, 2019
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients
U Krafft, S Tschirdewahn, J Hess, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 2, 2020
First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using <sup>68</sup>Ga-PSMA-11
Christopher Darr, U Krafft, W P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 27, 2012
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A Afshar-Oromieh, A Malcher, M Eder, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 6, 2013
Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A Afshar-Oromieh, A Malcher, M Eder, et al.
Molecular Imaging and Biology
|
September 5, 2019
Whole-Body Integrated [<sup>68</sup>Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference
Nika Guberina, P Hetkamp, H Ruebben, et al.
Prostate Cancer and Prostatic Diseases
|
May 18, 2016
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance
J P Radtke, T H Kuru, D Bonekamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2019
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
E J Small, F Saad, S Chowdhury, et al.
Prostate Cancer and Prostatic Diseases
|
June 17, 2015
Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance
J P Radtke, S Boxler, T H Kuru, et al.
Page
of 4